The Evidence-Based Guide to Managing Tamoxifen and Aromatase Inhibitor Side Effects: An Integrative Approach
By Remi Odisho
You are not imagining it.
When I first started working in integrative oncology, one thing became clear very quickly: most people were not looking for an alternative to their cancer treatment. They were looking for ways to tolerate it.
They wanted to know how to sleep again. How to manage aching joints. What to do about hot flushes that left them exhausted. Whether turmeric, green tea, fasting, soy foods or supplements were safe. And, often, they wanted to feel like themselves again.
For many people with hormone receptor-positive breast cancer, medications such as tamoxifen, letrozole, anastrozole and exemestane play an important role in reducing the risk of cancer recurrence. These medications can be incredibly effective, but they can also come with side effects that affect quality of life, confidence, sleep, energy, intimacy, mood and day-to-day functioning.
Here we’ll explore an evidence-based integrative approach to supporting people taking tamoxifen or aromatase inhibitors. The goal is not to replace oncology care, but to help you understand your options, ask better questions, and build a safe, personalised plan that works alongside your medical treatment.
Why endocrine therapy matters
Many breast cancers are described as hormone receptor-positive, meaning the cancer cells use hormones such as oestrogen to help them grow. Endocrine therapies are prescribed to reduce oestrogen signalling and lower the risk of recurrence.
Large clinical trial meta-analyses show that endocrine therapy substantially reduces recurrence risk in oestrogen receptor-positive breast cancer. Five years of tamoxifen has been shown to reduce recurrence rates compared with no endocrine therapy, and aromatase inhibitors reduce recurrence rates by about 30% proportionately compared with tamoxifen while treatment is being taken.
That is why side-effect management matters. If symptoms become unbearable, people may skip doses or stop treatment early. An integrative plan should support quality of life while also helping people remain safely engaged with their prescribed treatment.
Tamoxifen vs aromatase inhibitors: how are they different?
Tamoxifen and aromatase inhibitors are both used in hormone receptor-positive breast cancer, but they work in different ways.
Tamoxifen
Tamoxifen is a selective oestrogen receptor modulator, often shortened to SERM. This means it can block oestrogen activity in some tissues while having oestrogen-like effects in others.
In breast tissue, tamoxifen mainly acts as an anti-oestrogen. It binds to oestrogen receptors and helps block oestrogen from stimulating hormone-sensitive breast cancer cells.
However, tamoxifen can behave differently in other tissues. In the uterus, for example, it may have partial oestrogen-like activity, which is why it can be associated with endometrial thickening, polyps, hyperplasia and, in rare cases, endometrial cancer. ACOG notes that tamoxifen may be associated with endometrial proliferation, hyperplasia, polyp formation and uterine cancer, particularly in postmenopausal women.
This does not mean everyone taking tamoxifen needs to panic or request routine invasive testing. It does mean that new or unusual vaginal bleeding should always be investigated with your oncology or gynaecology team.
Aromatase inhibitors
Aromatase inhibitors include:
• Letrozole
• Anastrozole
• Exemestane
These medications work by blocking the aromatase enzyme, which converts androgens into oestrogens. After menopause, much of the body’s oestrogen is made through this aromatase pathway in tissues such as fat, adrenal, muscle and breast tissue. Aromatase inhibitors reduce circulating oestrogen levels and are mainly used in postmenopausal women, or in premenopausal women when combined with ovarian suppression.
Because aromatase inhibitors lower oestrogen more profoundly, their side effects often reflect low-oestrogen physiology such as joint pain, stiffness, vaginal dryness, bone density loss, hot flushes, sleep disturbance and changes in mood or cognition.
Why do side effects happen?
Oestrogen affects far more than reproductive tissue. It plays roles in:
• temperature regulation
• bone remodeling
• joint and connective tissue health
• vaginal and urinary tissue integrity
• sleep and circadian rhythms
• mood regulation
• cognition
• lipid and metabolic health
When oestrogen signalling is blocked or reduced, the body may respond with symptoms. This does not mean the medication is “bad” or that symptoms are inevitable. It means the body often needs additional support to adapt.
An integrative approach asks: How can we reduce symptom burden safely while respecting the importance of endocrine therapy?
The strongest evidence: exercise
If there is one intervention that belongs in almost every integrative oncology plan, it is exercise.
ASCO’s guideline on exercise, diet and weight management during cancer treatment recommends regular aerobic and resistance exercise during active treatment with curative intent to help mitigate side effects. The evidence base included dozens of systematic reviews and additional randomised controlled trials, with exercise improving cardiorespiratory fitness, strength, fatigue and other patient-reported outcomes.
For people taking aromatase inhibitors, exercise may be especially relevant for joint pain. The HOPE randomised exercise trial found that exercise improved aromatase inhibitor-induced arthralgia in previously inactive breast cancer survivors taking aromatase inhibitors.
What this can look like in real life
This does not mean you need to start with five gym sessions a week, a slow-consistent commitment to regular physical activity is recommended.A sustainable plan may include:
• walking
• gentle cycling
• supervised resistance training
• Pilates or strength-based yoga
• mobility and stretching
• gradual return to higher-intensity exercise
• weight-bearing exercise to support bone health
For someone experiencing significant fatigue or joint pain, the starting point may be very gentle. Consistency matters more than perfection.
Exercise has some of the strongest evidence for improving fatigue, function, strength and treatment-related symptoms. For aromatase inhibitor joint pain, a combined approach of movement, strength training, acupuncture and inflammation-informed nutrition may be more helpful than relying on one strategy alone.
Acupuncture for hot flushes, joint pain and quality of life
Acupuncture is one of the better-studied integrative therapies in breast cancer supportive care.
A large randomised clinical trial published in JAMA found that acupuncture was associated with statistically significant reductions in aromatase inhibitor-related joint pain at six weeks compared with sham acupuncture or waitlist control, and of those patients receiving acupuncture had reduced pain at 52 weeks compared with controls, thus suggesting a long-term benefit of treatment.
Acupuncture has also been studied for hot flushes in breast cancer survivors. In a randomised trial comparing electroacupuncture with gabapentin for hot flushes, researchers evaluated acupuncture as a non-hormonal option for a symptom that can be especially challenging in people who cannot use standard menopausal hormone therapy.
An ASCO-posted study also reported that acupuncture led to clinically meaningful improvements in hot flashes, endocrine symptoms and breast cancer-specific quality of life in women receiving adjuvant hormonal therapy.
What acupuncture may help with
Acupuncture may be considered as part of a broader plan for:
• hot flushes
• night sweats
• aromatase inhibitor joint pain
• sleep disturbance
• fatigue
• stress and nervous system regulation
• pain modulation
Acupuncture is not a magic cure, but it is a reasonable evidence-informed option for people wanting non-hormonal support for endocrine therapy side effects, especially when provided by a practitioner experienced in cancer care.
Diet and functional foods: what actually matters?
There is no single “breast cancer diet,” and no food has been proven to prevent recurrence on its own. That said, dietary patterns can influence inflammation, metabolic health, gut health, body composition, cardiovascular risk and overall wellbeing.
For breast cancer survivors, the World Cancer Research Fund and American Institute for Cancer Research have generally advised following cancer prevention recommendations where specific survivorship evidence is limited. These recommendations emphasise a pattern rich in wholegrains, vegetables, fruit and legumes, maintaining a healthy weight, being physically active, limiting highly processed foods and sugary drinks, and limiting alcohol.
A practical integrative dietary approach often focuses on:
• adequate protein to support muscle, immune function and tissue repair
• fibre from legumes, vegetables, fruit, nuts, seeds and wholegrains
• colourful polyphenol-rich foods such as berries, herbs, spices, green tea, extra virgin olive oil and cocoa
• omega-3 rich foods such as oily fish, chia, flax and walnuts
• soy foods where appropriate and tolerated
• fermented foods if tolerated
• reduced alcohol intake
• stable blood glucose and adequate energy intake
Soy foods: still misunderstood
Soy is one of the most common areas of fear and confusion after breast cancer.
Many patients are told to avoid soy because it contains isoflavones, which are sometimes described as “plant oestrogens.” However, food-based soy intake is not the same as taking high-dose isolated phytoestrogen supplements.
A 2023 systematic review and meta-analysis of phytonutrients and breast cancer outcomes found that soy isoflavones were associated with a reduced risk of recurrence, particularly among postmenopausal and oestrogen receptor-positive survivors. The same review noted that soy, enterolactone and green tea showed significant risk reductions in outcomes following breast cancer, while also calling for more research on post-diagnosis changes in intake.
Functional food examples
Rather than thinking in terms of “superfoods,” it is more helpful to think about consistent dietary patterns.
Examples include:
• Soy foods: tofu, tempeh, edamame, soy milk
• Fibre-rich foods: lentils, chickpeas, oats, chia seeds, vegetables
• Polyphenol-rich foods: berries, green tea, herbs, spices, extra virgin olive oil
• Cruciferous vegetables: broccoli, cauliflower, rocket, cabbage, Brussels sprouts
• Protein foods: fish, eggs, legumes, tofu, Greek yoghurt, nuts and seeds, lean animal proteins
• Bone-supportive foods: calcium-rich foods, vitamin D assessment, protein, resistance exercise
The best-supported dietary approach is not extreme restriction. It is a consistent, nutrient-dense, mostly wholefood pattern that supports metabolic health, gut health, body composition, cardiovascular health and treatment tolerance.
Curcumin: promising, but not automatically safe
Curcumin, the active compound found in turmeric, is one of the most commonly discussed supplements in integrative oncology. It has anti-inflammatory and cell-signalling effects in preclinical research, and it has been studied in some cancer-related supportive care settings.
For example, oral curcumin has been studied for radiation dermatitis in breast cancer patients, with some trials and reviews suggesting potential benefit in reducing severity.
However, curcumin becomes more complicated in people taking tamoxifen.
A pharmacokinetic study found that curcumin, with or without piperine, decreased exposure to tamoxifen and its active metabolite endoxifen. This matters because tamoxifen needs to be converted into active metabolites, including endoxifen, to exert its therapeutic effect.
My clinical framing
Turmeric as a food is very different from high-dose curcumin supplements, especially formulas containing piperine or other absorption enhancers.
For someone taking tamoxifen, I would not treat curcumin as a casual “wellness supplement.” It should be reviewed carefully in the context of:
• tamoxifen use
• CYP2D6 metabolism
• other medications
• bleeding risk
• surgery timing
• chemotherapy or radiotherapy
• liver function
• supplement dose and formulation
Curcumin may have therapeutic potential in certain settings, but for people taking tamoxifen, high-dose curcumin supplements should be assessed individually due to potential effects on tamoxifen and endoxifen exposure.
Green tea: dietary intake vs concentrated extracts
Green tea is another common topic in breast cancer research and survivorship.
Green tea contains catechins, including EGCG, which have antioxidant and cell-signalling effects. Observational research has explored whether green tea intake is associated with breast cancer outcomes. A 2023 systematic review reported that green tea was among the phytonutrients associated with significant risk reductions in breast cancer outcomes, but also highlighted the need for more evidence about introducing or substantially increasing intake after diagnosis.
The distinction between drinking green tea and taking high-dose green tea extract is important.
For many people, moderate green tea intake as part of a balanced diet is reasonable. Concentrated green tea extracts are different: they may have higher doses, greater risk of adverse effects, and more potential for interactions.
Green tea as a beverage may be appropriate for many breast cancer survivors, but high-dose green tea extracts should be reviewed with a practitioner, particularly during active treatment or when taking multiple medications.
Intermittent fasting and short-term fasting: early evidence, not a blanket recommendation
Fasting is one of the most popular and controversial topics in cancer nutrition.
There is emerging research exploring fasting, fasting-mimicking diets and short-term fasting around chemotherapy. The DIRECT trial studied a fasting-mimicking diet as an adjunct to neoadjuvant chemotherapy in HER2-negative breast cancer. The trial suggested some possible benefits in treatment response and cellular protection markers, but adherence was difficult and interpretation requires caution.
A related Nature Communications commentary described the overall DIRECT findings as negative for key endpoints such as chemotherapy-related adverse events and pathological complete response, while noting potentially interesting findings and the need for better-designed trials.
What about fasting while taking tamoxifen or aromatase inhibitors?
At this stage, fasting should not be promoted as a proven way to improve endocrine therapy outcomes or reduce recurrence. It may have a role for selected people when used for metabolic health, body composition, insulin resistance or personal preference, but it needs to be individualised.
Fasting may be inappropriate or risky for people with:
• low body weight
• active weight loss
• history of eating disorder
• diabetes or blood glucose instability
• frailty
• significant fatigue
• poor appetite
• intensive treatment schedules
• high stress load
• pregnancy or breastfeeding
• complex medication regimens
Fasting is an emerging area of research, not a routine recommendation for everyone. In breast cancer care, it should be used cautiously and only when it supports the person’s overall health, nutritional status and treatment plan.
What I would be cautious with
An evidence-based integrative approach is not just about what to add. It is also about knowing what to avoid.
Black cohosh
Black cohosh is often marketed for hot flushes. However, clinical trials in breast cancer survivors have not shown consistent benefit.
A phase III randomised placebo-controlled crossover trial found that black cohosh did not outperform placebo for hot flash scores; another randomised trial concluded it was not significantly more effective than placebo for most menopausal symptoms, including hot flash number and intensity.
A systematic review concluded that there was a lack of evidence supporting black cohosh for reducing hot flushes in breast cancer patients.
I do not routinely recommend black cohosh for breast cancer-related hot flushes because better-supported options exist.
Bio-identical hormones
The term “bio-identical” can sound safer than “hormone replacement therapy,” but this language can be misleading. Hormonal therapies still require careful risk assessment in people with a history of hormone receptor-positive breast cancer.
The HABITS randomised trial of hormone replacement therapy after breast cancer was stopped early due to safety concerns, and follow-up analyses reported increased recurrence risk in the hormone therapy arm.
This does not mean every local vaginal hormone option carries the same risk as systemic therapy, and this is an area where specialist advice is important. But systemic hormones, compounded bio-identical hormones and unsupervised hormone prescribing should not be treated as benign wellness interventions after hormone-sensitive breast cancer.
Hormone-based therapies after breast cancer should only be considered with specialist oncology or menopause guidance, not through unsupervised wellness prescribing.
Detox protocols and parasite cleanses
This is probably the area where I receive the most questions. After cancer treatment, many people feel an understandable desire to “cleanse” the body. Unfortunately, detox programs and parasite cleanses are often expensive, poorly regulated and unsupported by evidence.
The National Cancer Institute notes that complementary and alternative therapies should be discussed with the cancer care team because many approaches still require research, and NCCIH warns that herbal supplements may have side effects and may interact with cancer drugs.
Although detox protocols aren’t recommended, what I do suggest is cleaning up the diet, using gentler detoxification methods such as exercise and infrared sauna, and if applicable, gentle herbal support.
Supporting liver function, digestion and elimination through nutrition, hydration, fibre, movement and sleep is very different from aggressive detoxes, parasite cleanses or protocols that claim to remove cancer.
A practical symptom-by-symptom approach
Hot flushes and night sweats
Consider:
• acupuncture
• paced breathing and nervous system regulation
• reducing alcohol and spicy triggers if relevant
• cooling sleep environment
• regular exercise
• reviewing medications with the oncology team
• non-hormonal pharmacological options where appropriate
Avoid assuming all “menopause herbs” are safe after breast cancer.
Joint pain and stiffness
Consider:
• resistance training and mobility work
• gradual aerobic exercise
• acupuncture
• anti-inflammatory dietary pattern
• vitamin D assessment if clinically indicated
• omega-3 rich foods
• oncology review if symptoms threaten adherence
For aromatase inhibitor-related joint pain, tart cherry, exercise and acupuncture have randomised trial evidence supporting their use.
Fatigue
Consider:
• screening for iron, B12, vitamin D, thyroid and sleep issues where appropriate
• graded exercise
• adequate protein and total energy intake
• blood glucose stability
• sleep support
• stress physiology and pacing
• acupuncture or mindfulness-based strategies
Vaginal dryness and sexual discomfort
Consider:
• non-hormonal vaginal moisturisers
• lubricants
• pelvic floor physiotherapy
• sexual counselling or psycho-oncology support
• oncology or menopause specialist referral for persistent symptoms
This is a quality-of-life issue, not a superficial concern. It deserves proper care.
Bone health
This is especially relevant for aromatase inhibitor therapy.
Consider:
• DEXA monitoring as advised by the medical team
• resistance and impact-loading exercise (if safe)
• adequate protein
• calcium-rich foods
• vitamin D assessment
• medical bone-protective therapies where indicated
Weight and body composition changes
Weight change during endocrine therapy is common, but it is rarely solved by restriction alone.
Consider:
• strength training to protect muscle
• adequate protein
• fibre-rich meals
• sleep support
• insulin and blood glucose considerations
• stress and cortisol patterns
• realistic meal timing
• addressing fatigue and pain so movement becomes possible again
Supplements: individualised, not automatic
Supplements are not routinely necessary for everyone. They should be individualised based on:
• symptoms
• diet
• medications
• pathology results
• treatment stage
• safety and interaction risk
• personal goals
• oncology team recommendations
The supplement question is not simply:
“Is this natural?”
The better questions are:
• Is there evidence it helps this symptom?
• Is it safe with this medication?
• Could it interfere with tamoxifen metabolism?
• Could it affect bleeding risk, surgery or liver enzymes?
• Is the dose food-like or pharmacological?
• Is the product independently tested?
• Are we using it for a clear reason?
This is where integrative oncology can be helpful: not by recommending more supplements, but by helping patients make safer and more informed decisions.
When to speak with your oncology team
Please speak with your oncology, breast care nurse, GP or gynaecology team if you experience:
• new vaginal bleeding
• bleeding after menopause
• severe pelvic pain
• severe mood changes or depression
• thoughts of stopping medication
• severe joint pain affecting function
• unexplained weight loss
• persistent fatigue that feels disproportionate
• symptoms of blood clot such as leg swelling, chest pain or shortness of breath
• new neurological symptoms
• any supplement or therapy you are considering during treatment
Never stop tamoxifen or an aromatase inhibitor without speaking with your oncology team. If side effects are affecting your life, that is a reason to ask for more support, not a reason to suffer silently.
How an integrative oncology consultation can help
Every person experiences endocrine therapy differently.
Some people mainly struggle with joint pain. Others experience hot flushes, insomnia, vaginal dryness, fatigue, mood changes, digestive symptoms, weight changes or fear about recurrence. Some are overwhelmed by conflicting supplement advice online and simply want someone to help them sort evidence from marketing.
During an integrative oncology consultation, we review:
• your diagnosis and treatment history
• current medications
• endocrine therapy side effects
• pathology and relevant blood tests
• diet and nutritional intake
• gut health
• sleep and fatigue
• stress and nervous system load
• supplement safety
• movement and exercise capacity
• your goals and preferences
The aim is to create a plan that supports your quality of life while working alongside your oncology care.
This may include nutrition, functional foods, lifestyle medicine, acupuncture, pathology review, supplement review and practical strategies for managing side effects.
Final thoughts
You should not have to choose between quality of life and staying on treatment.
Tamoxifen and aromatase inhibitors can be important medications, but side effects deserve to be taken seriously. An evidence-based integrative approach can help bridge the gap between “just put up with it” and unsafe online advice promising miracle solutions.
The best care is collaborative, informed and personalised.
If you are struggling with tamoxifen, letrozole, anastrozole or exemestane side effects, an integrative oncology consultation can help you build a safe, evidence-informed plan to support your body, your treatment and your quality of life.
Book a naturopathic consultation to review your symptoms, medications, nutrition, supplements and treatment goals, and create a personalised plan that works alongside your oncology team.
Frequently asked questions
Can I take supplements with tamoxifen?
Some supplements may be safe, while others may interact with tamoxifen metabolism or affect treatment safety. Curcumin, especially with piperine, has been shown to reduce tamoxifen and endoxifen exposure in a pharmacokinetic study, so supplement use should be reviewed individually.
Is soy safe after breast cancer?
Food-based soy intake appears safe for many breast cancer survivors and may be associated with improved outcomes in observational research. This does not automatically apply to high-dose isolated isoflavone supplements.
What helps aromatase inhibitor joint pain?
Exercise and acupuncture have some of the strongest evidence. A combined plan may include resistance training, mobility work, walking, acupuncture, nutrition support and medical review if pain threatens adherence.
Is fasting recommended during breast cancer treatment?
Fasting and fasting-mimicking diets are emerging areas of research, especially around chemotherapy, but they are not suitable for everyone and should not be promoted as a proven recurrence-prevention strategy. Nutritional status, weight, treatment stage, diabetes risk and fatigue all matter.
Is fasting recommended during breast cancer treatment?
Fasting and fasting-mimicking diets are emerging areas of research, especially around chemotherapy, but they are not suitable for everyone and should not be promoted as a proven recurrence-prevention strategy. Nutritional status, weight, treatment stage, diabetes risk and fatigue all matter.
Is black cohosh safe for hot flushes after breast cancer?
The issue is not only safety; it is also effectiveness. Clinical trials have not shown consistent benefit for hot flushes in breast cancer survivors, so it is not usually my first choice.
Can acupuncture help with tamoxifen or aromatase inhibitor side effects?
Acupuncture has evidence for aromatase inhibitor-related joint pain and may help with hot flushes and quality-of-life symptoms in some people. It is best used as part of a broader supportive care plan.
By Remi Odisho
About the Author
Remi Odisho is an integrative naturopath and acupuncturist with a special interest in female reproductive health, digestion, hormones, and midlife transitions. Remi supports women through breast cancer treatment using evidence-based functional testing, personalised nutrition, lifestyle medicine, and integrative therapies to reduce treatment side effects and enhance recovery after treatment. Their approach is holistic, compassionate, and grounded in helping individuals feel informed, empowered, and supported through every stage of treatment.
Selected references
• Early Breast Cancer Trialists’ Collaborative Group. Aromatase inhibitors versus tamoxifen in early breast cancer meta-analysis.
• Pan H, et al. Twenty-year risks of breast-cancer recurrence after stopping endocrine therapy.
• Ligibel JA, et al. ASCO guideline: exercise, diet and weight management during cancer treatment.
• Irwin ML, et al. HOPE randomised exercise trial for aromatase inhibitor-induced arthralgia.
• Hershman DL, et al. Acupuncture for aromatase inhibitor-related joint pain: randomised clinical trial.
• Mao JJ, et al. Electroacupuncture versus gabapentin for hot flashes in breast cancer survivors.
• van Die MD, et al. Phytonutrients and outcomes following breast cancer: systematic review and meta-analysis.
• Hussaarts KGAM, et al. Curcumin and tamoxifen/endoxifen pharmacokinetics.
• de Groot S, et al. Fasting-mimicking diet as adjunct to neoadjuvant chemotherapy in breast cancer: DIRECT trial.
• Pockaj BA, et al. Black cohosh for hot flashes in breast cancer survivors: phase III randomised trial.
• Holmberg L, et al. HABITS trial of hormone replacement therapy after breast cancer.
• National Cancer Institute and NCCIH resources on complementary approaches and supplement safety in cancer care.
